Factor V Leiden and Risks of Recurrent Idiopathic Venous Thromboembolism
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Background Whether Leiden mutation in the gene coding for coagulation factor V is associated with recurrent idiopathic venous thromboembolism (VTE) is unknown, but such data are necessary to evaluate the merits of genetic screening in secondary prevention of thromboembolic disease. Methods and Results Among 14 916 apparently healthy men who provided DNA samples and were followed in the Physicians’ Health Study through August 1994, 77 suffered an idiopathic VTE. These 77 men were followed for an additional average period of 68.3 months, during which time 11 (14.3%) suffered a recurrent idiopathic VTE. Factor V Leiden status was assessed in these men, and incidence rates of recurrence were calculated by genotype. All recurrent events occurred after cessation of anticoagulation. Seven recurrences occurred among 63 genetically unaffected subjects (11.1%; incidence rate, 1.82 per 100 person-years), while four occurred among those 14 heterozygous for factor V Leiden (28.6%; incidence rate, 7.46 per 100 person-years). Thus, factor V Leiden was associated with a fourfold to fivefold increase in risk of recurrent VTE (crude relative risk, 4.1; P =.04; age- and smoking-adjusted relative risk, 4.7; P =.047). There was no difference in mean time between index and recurrent events by genotype. Among heterozygous men, 76% of recurrent events were attributable to mutation. Conclusions In prospective evaluation of 77 men with a history of idiopathic VTE, factor V Leiden was associated with a fourfold to fivefold increased risk of recurrent thrombosis. These data raise the possibility that patients with VTE affected by factor V Leiden may require more prolonged anticoagulation to prevent recurrent disease compared with those without mutation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vandenbroucke, J. P., Koster, T., Rosendaal, F. R., Briët, E., Reitsma, P. H., & Bertina, R. M. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90286-0 · Cited by 1,063
Cited by
Antithrombotic Therapy for Venous Thromboembolic Disease
Kearon, C., Kahn, S. R., Agnelli, G., Goldhaber, S., Raskob, G. E., & Comerota, A. J. (2008) · Chest · doi:10.1378/chest.08-0658 · Cited by 1,996
Self-citationHeit, J. A., Mohr, D. N., Silverstein, M. D., Petterson, T. M., O'Fallon, W. M., & Melton, L. J. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.6.761 · Cited by 1,352
Natural History of Venous Thromboembolism
Kearon, C. (2003) · Circulation · doi:10.1161/01.cir.0000078464.82671.78 · Cited by 1,048
Long-Term, Low-Intensity Warfarin Therapy for the Prevention of Recurrent Venous Thromboembolism
Ridker, P. M., Goldhaber, S. Z., Danielson, E., Rosenberg, Y., Eby, C. S., Deitcher, S. R., Cushman, M., Moll, S., Kessler, C. M., Elliott, C. G., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035029 · Cited by 808
Self-citationPrandoni, P., Noventa, F., Ghirarduzzi, A., Pengo, V., Bernardi, E., Pesavento, R., Iotti, M., Tormene, D., Simioni, P., & Pagnan, A. (2007) · Haematologica · doi:10.3324/haematol.10516 · Cited by 776
Epidemiology and Risk Factors for Venous Thrombosis
Cushman, M. (2007) · Seminars in Hematology · doi:10.1053/j.seminhematol.2007.02.004 · Cited by 755
Ridker, P. M. (1997) · JAMA · doi:10.1001/jama.1997.03540400055031 · Cited by 638
Self-citationA Prospective Study of Risk Factors for Pulmonary Embolism in Women
Goldhaber, S. Z. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540320044033 · Cited by 603
Self-citationThrombophilia, Clinical Factors, and Recurrent Venous Thrombotic Events
Christiansen, S. C. (2005) · JAMA · doi:10.1001/jama.293.19.2352 · Cited by 586
Residual Venous Thrombosis as a Predictive Factor of Recurrent Venous Thromboembolism
Prandoni, P., Lensing, A. W. A., Prins, M. H., Bernardi, E., Marchiori, A., Bagatella, P., Frulla, M., Mosena, L., Tormene, D., Piccioli, A., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-12-200212170-00008 · Cited by 547
Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease
Lane, D. A., & Grant, P. J. (2000) · Blood · doi:10.1182/blood.v95.5.1517.005k48_1517_1532 · Cited by 495
De Stefano, V., Martinelli, I., Mannucci, P. M., Paciaroni, K., Chiusolo, P., Casorelli, I., Rossi, E., & Leone, G. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909093411104 · Cited by 482
Goldhaber, S. Z. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807093390207 · Cited by 428
Self-citationSimioni, P., Prandoni, P., Lensing, A. W. A., Scudeller, A., Sardella, C., Prins, M. H., Villalta, S., Dazzi, F., & Girolami, A. (1997) · New England Journal of Medicine · doi:10.1056/nejm199702063360602 · Cited by 368
Interrelation of Hyperhomocyst(e)inemia, Factor V Leiden, and Risk of Future Venous Thromboembolism
Ridker, P. M., Hennekens, C. H., Selhub, J., Miletich, J. P., Malinow, M. R., & Stampfer, M. J. (1997) · Circulation · doi:10.1161/01.cir.95.7.1777 · Cited by 338
Self-citationRisk of Recurrent Venous Thromboembolism in Patients With Common Thrombophilia: A Systematic Review
Ho, W. K., Hankey, G. J., Quinlan, D. J., & Eikelboom, J. W. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.7.729 · Cited by 302
Investigation and management of heritable thrombophilia
Walker, I. D., Greaves, M., & Preston, F. E. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.02981.x · Cited by 299
Risk factors for venous thromboembolism
Heit, J. A. (2003) · Clinics in Chest Medicine · doi:10.1016/s0272-5231(02)00077-1 · Cited by 294
Risk Factors in Venous Thromboembolism
Martinelli, I. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1616237 · Cited by 291
Palareti, G., Legnani, C., Cosmi, B., Valdré, L., Lunghi, B., Bernardi, F., & Coccheri, S. (2003) · Circulation · doi:10.1161/01.cir.0000079162.69615.0f · Cited by 276
Ridker, P. M., Hennekens, C. H., & Miletich, J. P. (1999) · Circulation · doi:10.1161/01.cir.99.8.999 · Cited by 259
Self-citation
Metadata
- Authors
- Ridker, P. M., Miletich, J. P., Stampfer, M. J., Goldhaber, S. Z., Lindpaintner, K., & Hennekens, C. H.
- Venue
- Circulation
- Published
- 1995-11-15
- Volume
- 92
- Issue
- 10
- Pages
- 2800-2802
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2080396603
- Cited by
- 243
- References
- 1
- FWCI
- 9.66
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.